19th Bleeding and Thrombosing Diseases

The 19th Bleeding and Thrombosing Diseases is dedicated to laboratory and clinical aspects of bleeding and thrombosing disorders.

Key Topics

• Antibody-mediated prothrombotic disorders such as lupus anticoagulant, heparin-induced thrombocytopenia and antiphospholipid syndrome
• Clinical features and laboratory evaluation of congenital and acquired bleeding disorders including B, hemophilia A, von Willebrand disease and hereditary platelet disorders
• Features of the direct oral anticoagulant (DOAC) drugs including situations where use is appropriate versus not recommended, and options for DOAC reversal
• Key features of treatment of venous thromboembolism (VTE) including options for therapy and care for specialized patient populations with VTE (i.e., cancer patients)

Who should Attend

Attendees whose practices include bleeding and thrombosing diseases including:

• Pathologists
• Clinicians
• Nurse practitioners
• Physician assistants
• Scientists
• Laboratory technologists
• Nurses